J0610 HCPCS code: Injection, calcium gluconate (fresenius kabi), per 10 ml
J0610 is the HCPCS Level II code for injection, calcium gluconate (fresenius kabi), per 10 ml. CMS terminated J0610 on 2023-03-31; do not bill it for later dates of service. In 2023 Medicare paid an average of $3.77 per service for J0610 across 7,923 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. Medicare volume fell 74% from 2022 to 2023 (30,263 to 7,923 services). In 2023, about 486 clinicians billed Medicare for J0610 for 1,605 beneficiaries; California, New York, Texas accounted for 68% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1982-01-01 |
| Last action effective | 2023-04-01 |
| Terminated | 2023-03-31 |
Who bills J0610 (2023)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 486 |
| Medicare beneficiaries | 1,605 |
| States with claims | 19 |
| Share of services in top 3 states (California, New York, Texas) | 68% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0610, 2022–2023
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 30,263 | 3,493 | $4.09 | $3.21 |
| 2023 | 7,923 | 1,605 | $4.93 | $3.77 |
States with the most J0610 services (2023)
| State | Services | Avg. paid |
|---|---|---|
| California | 3,843 | $3.80 |
| New York | 687 | $3.54 |
| Texas | 602 | $3.75 |
| Florida | 509 | $3.68 |
| Virginia | 304 | $3.79 |
What changed for J0610
- 1982-01-01: J0610 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0610?
J0610 is the HCPCS Level II code for injection, calcium gluconate (fresenius kabi), per 10 ml. Short descriptor: "Calcium glucon (fresenius)".
How much does Medicare pay for J0610?
In 2023, the average Medicare payment was $3.77 per service (average allowed $4.93).
Does Medicare cover J0610?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
Related J06 codes
- J0600 — Injection, edetate calcium disodium, up to 1000 mg
- J0601 — Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
- J0602 — Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)
- J0603 — Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)
- J0604 — Cinacalcet, oral, 1 mg, (for esrd on dialysis)
- J0605 — Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)
- J0606 — Injection, etelcalcetide, 0.1 mg
- J0607 — Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)
- J0608 — Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)
- J0609 — Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)
- J0611 — Injection, calcium gluconate (wg critical care), per 10 ml
- J0612 — Injection, calcium gluconate, not otherwise specified, 10 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0610
- Watch J0610 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0610
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.